Trial · NCT01592370
Adverse event totals21
The totals the trial posted for each group.
1 to 20 of 21
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Nivolumab Monotherapy (Expansion) | 53 | 105 |
| Total, all-cause mortality | Nivolumab + Ipilimumab | 33 | 65 |
| Total, all-cause mortality | Nivolumab + Lirilumab | 42 | 72 |
| Total, all-cause mortality | Nivolumab + Daratumumab Cohort A1 | 1 | 6 |
| Total, all-cause mortality | Nivolumab + Daratumumab_Cohort A2 | 3 | 7 |
| Total, all-cause mortality | Nivolumab + Daratumumab_Cohort B1 | 24 | 42 |
| Total, all-cause mortality | Nivolumab + Daratumumab_Cohort B2 | 13 | 23 |
| Total, other adverse events | Nivolumab Monotherapy (Expansion) | 102 | 105 |
| Total, other adverse events | Nivolumab + Ipilimumab | 62 | 65 |
| Total, other adverse events | Nivolumab + Lirilumab | 69 | 72 |
| Total, other adverse events | Nivolumab + Daratumumab Cohort A1 | 6 | 6 |
| Total, other adverse events | Nivolumab + Daratumumab_Cohort A2 | 5 | 5 |
| Total, other adverse events | Nivolumab + Daratumumab_Cohort B1 | 35 | 41 |
| Total, other adverse events | Nivolumab + Daratumumab_Cohort B2 | 16 | 22 |
| Total, serious adverse events | Nivolumab Monotherapy (Expansion) | 50 | 105 |
| Total, serious adverse events | Nivolumab + Ipilimumab | 39 | 65 |
| Total, serious adverse events | Nivolumab + Lirilumab | 34 | 72 |
| Total, serious adverse events | Nivolumab + Daratumumab Cohort A1 | 3 | 6 |
| Total, serious adverse events | Nivolumab + Daratumumab_Cohort A2 | 5 | 5 |
| Total, serious adverse events | Nivolumab + Daratumumab_Cohort B1 | 15 | 41 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01592370/event-totals